Published in Nature on October 09, 1980
Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats. Transplantation (1995) 3.63
The lost chord: microchimerism and allograft survival. Immunol Today (1996) 2.81
A fail-safe mechanism for maintaining self-tolerance. J Exp Med (1992) 2.10
Haplotype-specific suppression of cytotoxic T cell induction by antigen inappropriately presented on T cells. J Exp Med (1983) 1.31
Influenza peptide-induced self-lysis and down-regulation of cloned cytotoxic T cells. Immunology (1990) 0.99
Interactions of allogeneic human mononuclear cells in the two-way mixed leucocyte culture (MLC): influence of cell numbers, subpopulations and cyclosporin. Clin Exp Immunol (1999) 0.97
In vivo administration of histoincompatible lymphocytes leads to rapid functional deletion of cytotoxic T lymphocyte precursors. J Exp Med (1989) 0.93
T-cell-mediated immune response in murine malaria: differential effects of antigen-specific Lyt T-cell subsets in recovery from Plasmodium yoelii infection in normal and T-cell-deficient mice. Infect Immun (1985) 0.90
Immune tolerance and transplantation. Semin Oncol (2012) 0.90
Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. J Exp Med (1992) 0.90
The surprising kinetics of the T cell response to live antigenic cells. J Immunol (2007) 0.90
A clinical trial combining donor bone marrow infusion and heart transplantation: intermediate-term results. J Thorac Cardiovasc Surg (2000) 0.89
CTLs respond with activation and granule secretion when serving as targets for T-cell recognition. Blood (2010) 0.87
Functional heterogeneity in allospecific cytotoxic T lymphocyte clones. I. CTL clones express strong anti-self suppressive activity. J Exp Med (1984) 0.87
Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells. Blood (2009) 0.85
Production of soluble suppressor factors by herpes simplex virus-stimulated splenocytes from herpes simplex virus-immune mice. J Virol (1985) 0.85
Clonal deletion of postthymic T cells: veto cells kill precursor cytotoxic T lymphocytes. J Exp Med (1992) 0.85
Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes. Mol Ther (2013) 0.84
Cloning of self-major histocompatibility complex antigen-specific suppressor cells from adult bone marrow. J Exp Med (1990) 0.83
H-2 restriction as a consequence of intentional priming. Frequency analysis of alloantigen-restricted, trinitrophenyl-specific cytotoxic T lymphocyte precursors within thymocytes of normal mice. J Exp Med (1981) 0.83
Advances on Non-CD4 + Foxp3+ T Regulatory Cells: CD8+, Type 1, and Double Negative T Regulatory Cells in Organ Transplantation. Transplantation (2015) 0.80
Cytotoxic T lymphocytes reactive against a syngeneic murine tumor and their specific suppressor T cells are both elicited by in vitro allosensitization. J Exp Med (1990) 0.80
Autoimmune syndrome after induction of neonatal tolerance to alloantigens: analysis of the role of donor T cells in the induction of autoimmunity. Clin Exp Immunol (1990) 0.79
The use of donor-derived veto cells in hematopoietic stem cell transplantation. Front Immunol (2012) 0.78
Inhibition of cytotoxic alloreactivity by human allogeneic mononuclear cells: evidence for veto function of CD2+ cells. Immunology (1998) 0.77
Hybrid antibody mediated veto of cytotoxic T lymphocyte responses. J Exp Med (1996) 0.77
The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT. Bone Marrow Transplant (2015) 0.75
MHC class II presenting cells are necessary for the induction of intrathymic tolerance. Ann Surg (1993) 0.75
Treatment of an autoimmune disease with "classical" T cell veto: a proposal. J Clin Immunol (1999) 0.75
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38
Separation of cells by velocity sedimentation. J Cell Physiol (1969) 8.73
The identification in adult bone marrow of pluripotent and restricted stem cells of the myeloid and lymphoid systems. J Exp Med (1977) 4.44
Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA (1979) 3.69
Initiation of antibody production to sheep erythrocytes in vitro: replacement of the requirement for T-cells with a cell-free factor isolated from cultures of lymphoid cells. J Immunol (1972) 2.83
Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2003) 2.76
Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease. J Immunol (1984) 2.56
Multifocal motor neuropathy: response to human immune globulin. Ann Neurol (1993) 2.32
In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia (2010) 2.22
Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature (1992) 2.22
Subacute, reversible motor neuron disease. Neurology (1991) 2.20
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
Reliability of the thermodilution method in the determination of cardiac output in clinical practice. Am Rev Respir Dis (1982) 2.07
Blunted pressor and intramuscular metabolic responses to voluntary isometric exercise in multiple sclerosis. J Appl Physiol (1985) (2000) 2.04
Allograft immunity in the mouse. II. Physical studies of the development of cytotoxic effector cells from their immediate progenitors. J Immunol (1973) 1.89
Quantitative studies of the activation of cytotoxic lymphocyte precursor cells. Immunol Rev (1977) 1.87
What price Kaplan-Meier? Biometrics (1983) 1.73
A quantitative assay for the progenitors of bone marrow-associated lymphocytes. J Exp Med (1972) 1.69
Quantitative analysis of the 51Cr release cytotoxicity assay for cytotoxic lymphocytes. Cell Immunol (1974) 1.68
Cyclosporine increases muscular force generation in Duchenne muscular dystrophy. Neurology (1993) 1.61
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology (2004) 1.60
Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res (1995) 1.57
Quantitative studies on the precursors of cytotoxic lymphocytes. I. Characterization of a clonal assay and determination of the size of clones derived from single precursors. J Immunol (1977) 1.57
Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet Med (2010) 1.56
Central basis of muscle fatigue in chronic fatigue syndrome. Neurology (1993) 1.52
Prognosis in AZT myopathy. Neurology (1991) 1.50
Differentiation of rosette-forming cells from myeloid stem cells. J Immunol (1970) 1.49
Homogeneity of antibody-producing cells as analysed by their buoyant density in gradients of Ficoll. Immunology (1970) 1.45
Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC). Diabetologia (2007) 1.44
In vivo requirement for a radiation-resistant cells in the immune response to sheep erythrocytes. J Exp Med (1971) 1.41
CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol (1996) 1.41
Diuresis in the ascitic patient: a randomized controlled trial of three regimens. J Clin Gastroenterol (1981) 1.39
Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells. Proc Natl Acad Sci U S A (1981) 1.37
Atomic force microscopy of purple membranes. J Microsc (1988) 1.35
Identification by density separation of antigen-specific surface receptors on the progenitors of antibody-producing cells. Immunology (1971) 1.35
Cells in bone marrow and in T cell colonies grown from bone marrow can suppress generation of cytotoxic T lymphocytes directed against their self antigens. J Exp Med (1980) 1.35
The use and abuse of filipin to localize cholesterol in membranes. Cell Biol Int Rep (1984) 1.29
Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol (1993) 1.27
The cubital tunnel syndrome: diagnosis and precise localization. Ann Neurol (1979) 1.25
Allograft immunity in the mouse. 1. Quantitation and specificity of cytotoxic effector cells after in vitro sensitization. J Immunol (1973) 1.25
Quantitative MR relaxometry study of muscle composition and function in Duchenne muscular dystrophy. J Magn Reson Imaging (1994) 1.24
Particle rosettes in the periaxonal Schwann cell membrane and particle clusters in the axolemma of rat sciatic nerve. Brain Res (1977) 1.23
Specific T cell receptor gene rearrangements at the site of muscle degeneration in Duchenne muscular dystrophy. J Immunol (1994) 1.23
Cell separation analysis of B and T lymphocyte differentiation. Transplant Rev (1975) 1.21
The natural history of amyotrophic lateral sclerosis. Neurology (1993) 1.21
Reconstitution of T cell-depleted spleen cell populations by factors derived from T cells. 3. Mechanism of action of T cell-derived factors. J Immunol (1973) 1.20
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
A preliminary evaluation of a prospective study of pulmonary function studies and symptoms of hypoventilation in ALS/MND patients. J Neurol Sci (2001) 1.19
Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumulated in G2 + M phases after irradiation of a solid tumor in vivo. Cancer Res (1979) 1.19
Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis. J Appl Physiol (1985) (1997) 1.16
Chlorine dioxide water disinfection: a prospective epidemiology study. Arch Environ Health (1981) 1.16
A method to codetect introduced genes and their products in gene therapy protocols. Nat Biotechnol (1996) 1.16
Synchronization of mouse L-cells by a velocity sedimentation technique. Biophys J (1970) 1.15
Alloreactive cytotoxic T cells can develop and function in mice lacking both CD4 and CD8. Eur J Immunol (1993) 1.14
Nerve conduction studies in infants and children. J Child Neurol (1986) 1.14
Opposite polarity of filipin-induced deformations in the membrane of condensing vacuoles and zymogen granules. Science (1980) 1.13
Mitogenic analysis of murine B-cell heterogeneity. J Exp Med (1978) 1.13
Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. Ann Neurol (1988) 1.13
Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology (2002) 1.12
Adiposity and mortality in type 1 diabetes. Int J Obes (Lond) (2009) 1.12
Early and late volume changes during erythroid differentiation of cultured Friend leukemic cells. J Cell Physiol (1977) 1.11
Sedimentation analysis of the cells in mice required to initiate an in vivo immune response to sheep erythrocytes. Proc Soc Exp Biol Med (1970) 1.11
A cell population in nu/nu spleen can prevent generation of cytotoxic lymphocytes by normal spleen cells against self antigens of the nu/nu spleen. J Immunol (1979) 1.10
Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity. J Immunol (1992) 1.10
Palliative care in amyotrophic lateral sclerosis. Neurol Clin (2001) 1.10
Central core disease: ultrastructure of the sarcoplasmic reticulum and T-tubules. Muscle Nerve (1989) 1.09
Growth at limiting dilution of human T cell colonies from T cell-depleted peripheral blood leukocytes. J Immunol (1983) 1.09
Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria. rhCNTF ALS Study Group. Neurology (1998) 1.09
Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology (1998) 1.09
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
In vitro differentiation of B lymphocytes from pre-B cells. J Immunol (1979) 1.09
Muscle membrane excitation and impulse propagation velocity are reduced during muscle fatigue. Muscle Nerve (1986) 1.08
Acquisition of concomitant oral and genital infection with herpes simplex virus type 2. Sex Transm Dis (1987) 1.08
Quantitative studies on the precursors of cytotoxic lymphocytes. VI. Second signal requirements of specifically activated precursors isolated 12 h after stimulation. J Exp Med (1980) 1.08
Quantitative studies on the precursors of cytotoxic lymphocytes. V. The cellular basis for the cross-reactivity of TNP-specific clones. J Immunol (1978) 1.07
Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science (1991) 1.06
Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-14. Neurology (1995) 1.06
Restriction of specificity in the precursors of bone marrow-associated lymphocytes. J Exp Med (1973) 1.05
Peripheral tolerance through clonal deletion of mature CD4-CD8+ T cells. Int Immunol (1992) 1.05
Sporadic distal myopathy with early adult onset. Ann Neurol (1979) 1.05
Volume analysis of human peripheral blood leukocytes. Ser Haematol (1972) 1.05
Current management of ALS: comparison of the ALS CARE Database and the AAN Practice Parameter. The American Academy of Neurology. Neurology (2001) 1.05
Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve (2005) 1.04
Membrane particles on fracture faces of frozen myelin. Proc Natl Acad Sci U S A (1975) 1.04
Marrow environment not required for differentiation of B lymphocytes. Nature (1974) 1.04
Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve (1998) 1.03
Inhibition of the immune response by 7S antibody mechanism and site of action. J Exp Med (1973) 1.03
Chancroidal ulcers that are not chancroid. Cause and epidemiology. Arch Dermatol (1984) 1.02
Conduction block in clinical practice. Muscle Nerve (1991) 1.02
Quantitative studies on the precursors of cytotoxic lymphocytes. II. Specificity of precursors responsive to alloantigens and to concanavalin A. J Immunol (1977) 1.01
Measurement of cytoplasmic fluorescence depolarization of single cells in a flow system. J Histochem Cytochem (1977) 1.00
Do 'lipidic particles' represent intermembrane attachment sites? Nature (1980) 1.00
A modified 51Cr release assay for cytotoxic lymphocytes. J Immunol Methods (1974) 0.99
Subacute structural myopathy associated with human immunodeficiency virus infection. Arch Neurol (1988) 0.98